Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Avantogen Oncology Ltd.

Division of Acuvax Ltd.

Latest From Avantogen Oncology Ltd.

Investment gains to advance Acuvax's vaccine ambitions

Acuvax has divested to an unnamed European company its 10% holding in the private German oncology firm RESprotect. The Australian venture retains an interest in RESprotect's lead project, RP101 (BVdU), which is being developed by SciClone Pharmaceuticals.


Hawaii Biotech appoints Avantogen CEO to its board of directors

Hawaii Biotech, a biotechnology company focused on vaccine development, has appointed Dr William Ardrey to its board of directors. Dr Ardrey is CEO of Avantogen, which develops drugs in the oncology and vaccine markets, and which has a substantial stake in Hawaii Biotech. Dr Ardrey will both support Hawaii Biotech's development activities – the company recently began a trial into a vaccine for West Nile virus, and plans a Phase I trial for dengue fever next year – and bring investment to the company, with Avantogen planning to purchase additional shares in the company. The position is effective from October 21st.

Orthopedics Companies

Hawaii Biotech receives WRAIR support for dengue vaccine programme

Hawaii Biotech has announced it will receive additional support for its dengue vaccine programme from the US Walter Reed Army Institute of Research (WRAIR).

Orthopedics Somalia
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Innovate Oncology Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Acuvax Ltd.
  • Senior Management
  • Chris Nowers, CEO
  • Contact Info
  • Avantogen Oncology Ltd.
    Phone: (310) 279-2932
    2121 Avenue of the Stars
    Ste. 2550
    Los Angeles , CA 90067